Buyung Poetra Sembada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Buyung Poetra Sembada Tbk. trades at Rp55 (market cap 532.28B, 5.77M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Buyung Poetra Sembada Tbk. is far larger — about 3.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Buyung Poetra Sembada Tbk. is more actively traded (5.77M versus 187.4K). Which is the better fit depends on your goals.
| HOKI | OBAT | |
|---|---|---|
Market Cap | 532.28B | 164.65B |
Volume | 5.77M | 187.4K |
Lot | 57.68K | 1.87K |
Turnover | 317.26M | 44.35M |
Average Price | 55 | 236.67 |
Value | 317.26M | 44.35M |
Indicative Equilibrium Price | 55 | 242 |
Indicative Equilibrium Volume | 520 | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Buyung Poetra Sembada Tbk (the “Company”) was established based on Notarial Deed No. 46 ofIchsan Tedjabuana, S.H., dated September 16, 2003.
Read more on HOKI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →